期刊文献+

TRAF6在常见妇科疾病中的相关研究进展

Research Progress of TRAF6 in Related Common Gynecologic Diseases
下载PDF
导出
摘要 肿瘤坏死因子受体相关因子6(TRAF6)是一种重要的细胞质连接分子,属于肿瘤坏死因子超家族和Toll样/白细胞介素-1受体超家族。TRAF6在许多组织中均表达,特别是在脑、肺、肝、骨骼肌和肾脏中表达较丰富。TRAF6在常见女性生殖系统疾病(如宫颈癌、卵巢癌、子宫内膜炎、子宫平滑肌瘤和卵巢早衰)中的功能多样、作用机制复杂,且存在表达失调,TRAF6的异常表达与妇科恶性肿瘤及炎症性疾病等密切相关,对疾病诊断和治疗具有潜在价值,可能是未来的研究方向之一。 Tumor necrosis factor receptor-associated factor 6(TRAF6)is an important cytoplasmic junction molecule,which belongs to the tumor necrosis factor superfamily and Toll-like/interleukin-1 receptor superfamily.It is normally expressed in many tissues,especially abundant in the brain,lungs,liver,skeletal muscles,and kidneys.TRAF6 has diverse functions,complex mechanism of action and dysregulation of expression in common female reproductive system diseases(such as cervical cancer,ovarian cancer,endometritis,uterine leiomyoma and premature ovarian failure).The abnormal expression of TRAF6 is closely related to malignant gynecologic tumors and inflammatory diseases,which has potential value for the disease diagnosis and treatment,and may be one of the research directions in the future.
作者 黄锦源 代荫梅 HUANG Jinyuan;DAI Yinmei(Department of Gynecology,Beijing Obstetrics and Gynecology Hospital,Capital Medical University.Beijing Maternal and Child Health Care Hospital,Beijing 100026,China)
出处 《医学综述》 CAS 2021年第21期4222-4227,共6页 Medical Recapitulate
关键词 妇科疾病 肿瘤坏死因子受体相关因子6 宫颈癌 卵巢癌 子宫内膜炎 Gynecologic diseases Tumor necrosis factor receptor-associated factor 6 Cervical cancer Ovarian cancer Endometritis
  • 相关文献

参考文献10

二级参考文献112

  • 1宫颈癌及癌前病变规范化诊疗指南(试行)[J].慢性病学杂志,2013(6):401-410. 被引量:98
  • 2张苗苗,阴梅云.凋亡相关因子与卵巢肿瘤研究进展[J].国外医学(肿瘤学分册),2004,31(9):709-713. 被引量:2
  • 3Dotti G, Savoldo B, Yotnda P, et al. Transgenic expression of CD40 ligand produces an in vivo antitumor immunere sponse against both CD40+ and CD40- plasmacytoma cells[J]. Blood, 2002, 100(1) : 200 -207. 被引量:1
  • 4Caux C, Massacrier C, Vanbervlier B, et al. Activation of human dendritic cells through CD40 cross -linking[ J]. J Exp Med, 1994, 180(4): 1263-1272. 被引量:1
  • 5Ciaravino G, Bhat M, Manbeian CA, et al. Differential expression of CD40 and CD95 in ovarian carcinoma [ J ].Eur J Gynaecol Oncol, 2004, 25 ( 1 ) : 27 - 32. 被引量:1
  • 6Schlienger K, Chu CS, Woo EY, et al. TRANCE - and CD40 ligand -matured dendritic cells reveal MHC class Ⅰ- restricted T cells specific for autologous tumor in late -stage ovarian cancer patients[ J]. Clin Cancer Res, 2003,9(4) : 1517 - 1527. 被引量:1
  • 7von l.eoprechting A, vonder Bruggen P, Pahl HL, et al.Stimulation of CD40 on immunogenic human malignant melanomas augments their cytotoxic T lymphocyte - mediated lysis and induces apoptosis [ J ]. Cancer Res, 1999,59(6) : 1287 - 1294. 被引量:1
  • 8Lu LF, Cook W J, Lin LL, et al. CD40 signaling through a newly identified tumor necrosis factor receptor - associated factor 2 ( TRAF2 ) binding site [ J ]. J Biol Chem,2003, 278(46) : 45414 -45418. 被引量:1
  • 9Hostager BS, Haxhinasto SA, Rowland SL, et al. Tumor necrosis factor receptor - associated factor 2 ( TRAF2 ) -deficient B lymphocytes reveal novel roles for TRAF2 in CD40 signaling [ J ]. J Biol Chem, 2003, 278 ( 46 ) :45382 - 45390. 被引量:1
  • 10Li C, Ni CZ, Havert ML, et al. Downstream regulator TANK binds to the CD40 recognition site on TRAF3 [ J ].Structure, 2002, 10(3) : 403 -411. 被引量:1

共引文献61

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部